INGENIA THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Dec 2022)
What this means for you
This application is over — abandoned 19 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88393561
- Mark type
- Design + words
- Filed
- 19 Apr 2019
- Published for opposition
- 17 Sept 2019
- Abandoned
- 19 Dec 2022
- Attorney of record
- Jenevieve Maerker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields
Owner
- INGENIA THERAPEUTICS INC, Cambridge, MA, US
- INGENIA THERAPEUTICS INC, Winchester, MA, US
Prosecution history
- 19 Dec 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Dec 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 13 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 May 2022 — SOU EXTENSION 5 GRANTED
- 05 May 2022 — SOU EXTENSION 5 FILED
- 12 May 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 May 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Nov 2021 — SOU EXTENSION 4 GRANTED
- 01 Nov 2021 — SOU EXTENSION 4 FILED
- 01 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2021 — SOU EXTENSION 3 GRANTED
- 28 Apr 2021 — SOU EXTENSION 3 FILED
- 28 Apr 2021 — SOU TEAS EXTENSION RECEIVED